- Home
- SGMT vs PERF Comparison
SGMT vs PERF Comparison
Compare SGMT & PERF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGMT | PERF |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | United States | Taiwan |
| Employees | N/A | 353 |
| Industry | | Computer Software: Prepackaged Software |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.4M | 172.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SGMT | PERF |
|---|---|---|
| Price | $6.94 | $1.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $26.13 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 65.7K |
| Earning Date | 05-14-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | $12.93 |
| Revenue Next Year | N/A | $9.44 |
| P/E Ratio | ★ N/A | $26.42 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.15 | $1.24 |
| 52 Week High | $11.41 | $2.67 |
Technical Indicators
Market Signals| Indicator | SGMT | PERF |
|---|---|---|
| Relative Strength Index (RSI) | 48.51 | 52.49 |
| Support Level | $6.07 | $1.68 |
| Resistance Level | $7.20 | $1.80 |
| Average True Range (ATR) | 0.62 | 0.04 |
| MACD | -0.15 | -0.00 |
| Stochastic Oscillator | 1.32 | 38.79 |
Price Performance
Historical ComparisonAbout SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About PERF Perfect Corp.
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.